Immucell (ICCC) EPS (Diluted) Growth (3y) (2013 - 2026)
Powered by 
Analysis
Immucell (ICCC) EPS (Diluted) Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.36 Bn | 40.16 Bn | 779.09 Mn | 16.91% |
| 2 | Zoetis | 29.60 Bn | 27.92 Bn | 1.05 Bn | 3.25% |
| 3 | Elanco Animal Health | 11.20 Bn | 10.67 Bn | 798.00 Mn | 36.48% |
| 4 | Phibro Animal Health | 1.40 Bn | 1.32 Bn | 134.40 Mn | 35.64% |
| 5 | Immucell | 90.37 Mn | 81.51 Mn | 2.44 Mn | 46.14% |
| 6 | Zhengye Biotechnology Holding | 64.93 Mn | 65.85 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -8.22% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46.14% |
| Dec 31, 2025 | -25.50% |
| Sep 30, 2025 | 43.26% |
| Jun 30, 2025 | 34.80% |
| Mar 31, 2025 | 19.49% |
| Dec 31, 2024 | 110.07% |
| Sep 30, 2024 | -87.09% |
| Jun 30, 2024 | -133.84% |
| Mar 31, 2024 | 2.59% |
| Dec 31, 2023 | 57.00% |
| Sep 30, 2023 | -39.43% |
| Jun 30, 2023 | -18.82% |
| Mar 31, 2023 | -160.26% |
| Dec 31, 2022 | -47.78% |
| Sep 30, 2022 | -6.65% |
| Jun 30, 2022 | -12.45% |
| Mar 31, 2022 | 54.70% |
| Dec 31, 2021 | 27.39% |
| Sep 30, 2021 | 34.16% |
| Jun 30, 2021 | 28.56% |